Search - tctmd.com

Displaying 461 - 480 of 702

Sort: Relevancy | Date

Presentation TCT 2019

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

Presenter: Toby Rogers

September 25, 2019

Presentation TCT 2019

TCT 35: Redo Transcatheter Aortic Valve Replacement for Structural and Non-Structural Transcatheter Valve Dysfunction: Initial Experience From a Single High-Volume Center

Presenter: Lisa Crusius

September 25, 2019

$TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing$

Presentation TCT 2019

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Presenter: Janarthanan Sathananthan, MD

September 25, 2019

Presentation TCT 2019

Transcatheter Aortic Valve Replacement in Complex Anatomy

Presenter: Futoshi Yamanaka, MD

September 25, 2019

Session II: RCIS Advanced Session — Interventional Hemodynamics of the Aortic Valve - Transcatheter Aortic Valve Replacement and How I Treated My Patient

Presentation TCT 2019

Transcatheter Aortic Valve Replacement and How I Treated My Patient

Presenter: Paul Mahoney

September 25, 2019

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

News Conference News TCT 2018

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

Lucy Hicks

September 26, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Wojtek Wojakowski, Mirvat Alasnag, Ori Ben-Yehuda, Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Mohamed Ahmed Sobhy, Pedro de Araujo Goncalves

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population

Presenter: Horst Sievert, Brian K. Whisenant, Marco Barbanti

September 23, 2018

Presentation TCT 2018

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Presenter: Horst Sievert, Brian K. Whisenant, Jeffrey J. Popma

September 23, 2018

Presentation TCT 2018

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Presenter: Valentin Fuster, Howard C. Herrmann

September 23, 2018

Presentation TCT 2018

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Presenter: Alfredo Trento

September 22, 2018

Presentation TCT 2018

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Presenter: Michael J. Mack

September 22, 2018

Presentation TCT 2018

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Presenter: Patrick T. O'Gara

September 22, 2018

Presentation TCT 2018

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Presenter: Martin B. Leon

September 22, 2018

Presentation TCT 2018

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Presenter: Joseph E. Bavaria

September 22, 2018

Presentation TCT 2018

Opinion Concerns of TAVR Access for Underserved Populations

Presenter: Aaron Horne, Jr.

September 22, 2018

Advertisement

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

TCT 35: Redo Transcatheter Aortic Valve Replacement for Structural and Non-Structural Transcatheter Valve Dysfunction: Initial Experience From a Single High-Volume Center

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Transcatheter Aortic Valve Replacement in Complex Anatomy

Transcatheter Aortic Valve Replacement and How I Treated My Patient

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

High Mortality but Durable Results With Valve-in-Valve TAVR

OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Opinion Concerns of TAVR Access for Underserved Populations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content